Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment
1 other identifier
interventional
54
0 countries
N/A
Brief Summary
The primary objective of this case-control intervention study to explore the effectiveness of non surgical periodontal therapy on the gingival crevicular fluid (GCF) levels of sclerostin in patients with chronic periodontitis (CP) so as to get a more detailed insight into its diagnostic and prognostic potential as a biomarker of periodontal disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Dec 2013
Shorter than P25 for early_phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 18, 2015
CompletedFirst Posted
Study publicly available on registry
March 17, 2015
CompletedSeptember 30, 2015
March 1, 2015
10 months
February 18, 2015
September 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemical parameters (Sclerostin levels, RANKL/OPG ratio )
The changes in levels of sclerostin, OPG and RANKL 6 weeks after periodontal treatment determined by ELISA. The changes in levels of sclerostin were analyzed to determine diagnostic and prognostic potential as a biomarker of periodontal disease. The relative RANKL/OPG ratio (bone resorption marker) was also calculated to detect the relationship between sclerostin levels.
Baseline and 6 weeks after treatment
Secondary Outcomes (5)
Probing pocket depth
Baseline and 6 weeks after treatment
Probing pocket depth and clinical attachment level
Baseline and 6 weeks after treatment
Gingival index
Baseline and 6 weeks after treatment
Plaque index
Baseline and 6 weeks after treatment
Bleeding on probing
Baseline and 6 weeks after treatment
Study Arms (2)
Chronic periodontitis
ACTIVE COMPARATORGCF samples were taken before and after treatment chronic periodontitis patients. Intervention: Non- surgical periodontal treatment (SRP and oral hygiene instructions)
clinically healthy periodontium
PLACEBO COMPARATORGCF samples were taken at baseline Intervention: oral hygiene instructions
Interventions
1. SRP under local anaesthesia, in a total of four clinical visits 2. Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
Eligibility Criteria
You may qualify if:
- Criteria for the healthy group were GI = 0, PPD and CAL ≤ 3 mm, and no signs of attachment and bone loss
- Criteria for the chronic periodontitis group were clinical signs of inflammation, such as red color and swelling of the gingival margin, GI ≥ 2, PPD and CAL ≥ 5 mm with bone loss (\>30% of the existing teeth)
You may not qualify if:
- Aggressive periodontitis, systemic diseases (i.e., diabetes mellitus, cancer, human immunodeficiency virus, bone-related diseases that compromise sclerostin, OPG or RANKL levels and collagen-metabolic diseases, or disorders), chronic high-dose steroid therapy, radiation or immunosuppressive therapy, allergy or sensitivity to any drug, pregnancy, lactation, and current smoking, smoking within the past 5 years. The individuals had no history of periodontal therapy or drug therapy (e.g. anti-inflammatory, antibiotic treatment or any other pharmacological treatment) for at least six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umut BALLIlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NON RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Bulent Ecevit University
Study Record Dates
First Submitted
February 18, 2015
First Posted
March 17, 2015
Study Start
December 1, 2013
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
September 30, 2015
Record last verified: 2015-03